Dataset Information


First-trimester levels of pregnancy-associated plasma protein A2 (PAPP-A2) in the maternal circulation are elevated in pregnancies that subsequently develop preeclampsia.

ABSTRACT: Recent studies have consistently found pregnancy-associated plasma protein A2 (PAPP-A2) to be upregulated in preeclamptic placentae at term. We tested whether first-trimester circulating PAPP-A2 levels differed between complicated and uncomplicated pregnancies. We measured maternal PAPP-A2 levels at 10 to 14 weeks of gestational age in 17 pregnancies resulting in small-for-gestational-age (SGA) infants, 6 which developed preeclampsia (PE), 1 which developed PE and resulted in an SGA infant, and 37 gestational age-matched controls. The concentration of the PAPP-A2 isoform corresponding to the full-length protein was significantly higher in pregnancies that developed PE (35 ng/mL) compared with those that did not (23 ng/mL; P < .044). In contrast, we found no difference in PAPP-A2 levels between pregnancies that did or did not result in an SGA infant. The upregulation of PAPP-A2 that has previously been observed in PE at term appears to begin early in pregnancy, well before the symptoms develop.


PROVIDER: S-EPMC4016723 | BioStudies | 2014-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2016-01-01 | S-EPMC4848394 | BioStudies
1000-01-01 | S-EPMC5996520 | BioStudies
2014-01-01 | S-EPMC4198481 | BioStudies
2020-01-01 | S-EPMC7238294 | BioStudies
2020-01-01 | S-EPMC7492290 | BioStudies
2019-01-01 | S-EPMC6884581 | BioStudies
2017-01-01 | S-EPMC5718699 | BioStudies
2020-01-01 | S-EPMC7105368 | BioStudies
2019-01-01 | S-EPMC6402211 | BioStudies
2008-01-01 | S-EPMC2587364 | BioStudies